SM
BLUE

Sabby Management’s bluebird bio BLUE Stock Holding History

Sabby Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-37
Closed -$8.64M – 163
2017
Q4 		$8.64M Sell
37
-7
-16% -$14.2K 0.79% 26
2017
Q3 		$7.76M Buy
44
+7
+19% +$9.78K 0.51% 25
2017
Q2 		$4.97M Buy
37
+31
+517% +$37.4K 0.33% 39
2017
Q1 		$654K Buy
+6
New +$6.12K 0.04% 161
2016
Q1 		– Sell
-40
Closed -$3.31M – 308
2015
Q4 		$3.31M Buy
40
+9
+29% +$8.99K 0.18% 85
2015
Q3 		$3.47M Sell
31
-38
-55% -$69.3K 0.14% 109
2015
Q2 		$15M Buy
69
+38
+123% +$77.4K 0.55% 37
2015
Q1 		$4.92M Buy
+31
New +$40.9K 0.2% 78

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sabby Management's BLUE Position: Q1 2016 in Review

Sabby Management sold out of bluebird bio (BLUE) in Q1 2016, closing a stake of 3,509 shares — an estimated $2.92M sold.

Sabby Management first reported a position in BLUE in Q4 2013 and held it in 4 quarters. The position peaked at $2.92M in Q4 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

  • Sabby Management reported no remaining bluebird bio position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 3,509 bluebird bio shares in Q1 2016, an estimated $2.92M.
  • Sabby Management first reported a position in bluebird bio in Q4 2013 and held it in 4 quarters.
  • Sabby Management's bluebird bio position peaked at $2.92M in Q4 2015.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.